First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group.
Colao
A
A
Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Via Pansini 5, 80131 Napoli, Italy. colao@unina.it
Martino
E
E
Cappabianca
P
P
Cozzi
R
R
Scanarini
M
M
Ghigo
E
E
D000172:Acromegaly / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D000236:Adenoma / Q000601:surgery; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use; D006801:Humans; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
D018491:Dopamine Agonists; D004873:Ergolines; D013004:Somatostatin; D000077465:Cabergoline